Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01194 | 34831201 | Cells | Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. | 2021 | Details |
| A01199 | 34830313 | Int J Mol Sci | Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01200 | 34830072 | Int J Mol Sci | T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01213 | 34828259 | Genes (Basel) | Aberrant DNA Methylation Mediates the Transgenerational Risk of Metabolic and Chronic Disease Due to Maternal Obesity and Overnutrition. | 2021 | Details |
| A01214 | 34827721 | Biomolecules | The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01227 | 34822395 | Metabolites | Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted 1H-NMR Metabolomics. | 2021 | Details |
| A01257 | 34813379 | Metab Syndr Relat Disord | The Myristic Acid:Docosahexaenoic Acid Ratio Versus the n-6 Polyunsaturated Fatty Acid:n-3 Polyunsaturated Fatty Acid Ratio as Nonalcoholic Fatty Liver Disease Biomarkers. | 2021 | Details |
| A01281 | 34803499 | Int J Biol Sci | CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD+/Sirtuins Signaling Pathways-Mediated Inhibition of Lipid Accumulation and Oxidative Stress in Hepatocytes. | 2021 | Details |
| A01283 | 34803490 | Int J Biol Sci | SOCS2 Suppresses Inflammation and Apoptosis during NASH Progression through Limiting NF-κB Activation in Macrophages. | 2021 | Details |
| A01291 | 34800721 | Ann Hepatol | Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C. | 2021 | Details |
| A01308 | 34794234 | Biomed Pharmacother | Saroglitazar and Hepano treatment offers protection against high fat high fructose diet induced obesity, insulin resistance and steatosis by modulating various class of hepatic and circulating lipids. | 2021 | Details |
| A01315 | 34790034 | Int J Med Sci | Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study. | 2021 | Details |
| A01332 | 34786174 | World J Hepatol | Serum zonulin levels in patients with liver cirrhosis: Prognostic implications. | 2021 | Details |
| A01338 | 34783592 | Radiology | Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease. | 2021 | Details |
| A01350 | 34778544 | Transplant Direct | Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. | 2021 | Details |
| A01355 | 34777261 | Front Endocrinol (Lausanne) | Endotoxins and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01373 | 34771023 | Molecules | Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury. | 2021 | Details |
| A01375 | 34769333 | Int J Mol Sci | Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD. | 2021 | Details |
| A01392 | 34762779 | Arch Endocrinol Metab | Acoustic radiation force impulse elastography and liver fibrosis risk scores in severe obesity. | 2021 | Details |
| A01417 | 34755544 | J Am Heart Assoc | Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries. | 2021 | Details |
| A01422 | 34754150 | World J Gastroenterol | Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? | 2021 | Details |
| A01426 | 34752964 | Clin Gastroenterol Hepatol | Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study. | 2021 | Details |
| A01437 | 34746195 | Front Med (Lausanne) | Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies. | 2021 | Details |
| A01446 | 34742934 | Arch Biochem Biophys | The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids. | 2021 | Details |
| A01462 | 34739937 | Nutrition | Comparison of bioelectrical impedance analysis, mass index, and waist circumference in assessing risk for non-alcoholic steatohepatitis. | 2021 | Details |
| A01463 | 34738990 | J Hypertens | Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus. | 2021 | Details |
| A01498 | 34722615 | Front Nutr | Role of the Aryl Hydrocarbon Receptor and Gut Microbiota-Derived Metabolites Indole-3-Acetic Acid in Sulforaphane Alleviates Hepatic Steatosis in Mice. | 2021 | Details |
| A01505 | 34718898 | Egypt Heart J | The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography. | 2021 | Details |
| A01520 | 34710482 | J Hepatol | Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease. | 2021 | Details |
| A01539 | 34705426 | ACS Nano | Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01543 | 34704005 | JHEP Rep | PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation. | 2021 | Details |
| A01547 | 34697932 | J Korean Med Sci | Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort. | 2021 | Details |
| A01560 | 34693553 | J Gastroenterol Hepatol | Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population-based study. | 2021 | Details |
| A01565 | 34691178 | J Oncol | Main Risk Factors of Type 2 Diabetes Mellitus with Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma. | 2021 | Details |
| A01566 | 34690666 | Int J Public Health | Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis. | 2021 | Details |
| A01588 | 34684510 | Nutrients | Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis. | 2021 | Details |
| A01601 | 34681695 | Int J Mol Sci | Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity. | 2021 | Details |
| A01627 | 34677008 | Hepatol Commun | Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01628 | 34676692 | Hepatol Commun | Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus. | 2021 | Details |
| A01637 | 34674510 | Endocrinol Metab (Seoul) | Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study. | 2021 | Details |
| A01640 | 34671210 | Int J Biol Sci | Lrp6 Genotype affects Individual Susceptibility to Nonalcoholic Fatty Liver Disease and Silibinin Therapeutic Response via Wnt/β-catenin-Cyp2e1 Signaling. | 2021 | Details |
| A01646 | 34669440 | Sci Transl Med | Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors. | 2021 | Details |
| A01647 | 34669319 | Minerva Endocrinol (Torino) | Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver disease. | 2021 | Details |
| A01658 | 34664321 | J Clin Lab Anal | Association between apolipoprotein E gene polymorphism and nonalcoholic fatty liver disease in Southern China: A case-control study. | 2021 | Details |
| A01662 | 34663576 | Diabetes | Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity. | -- | Details |
| A01664 | 34662928 | Pediatr Obes | Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction. | 2021 | Details |
| A01666 | 34662449 | Hepatology | Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis. | 2022 | Details |
| A01670 | 34660454 | J Family Med Prim Care | Association of Obstructive Sleep Apnea with Nocturnal Hypoxemia in Metabolic-Associated Fatty Liver Disease Patients: A Cross-sectional Analysis of Record-based Data. | 2021 | Details |
| A01708 | 34648769 | Metabolism | Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study. | 2021 | Details |
| A01719 | 34640643 | J Clin Med | Fibrosis Burden of Missed and Added Populations According to the New Definition of Metabolic Dysfunction-Associated Fatty Liver. | 2021 | Details |
| A01723 | 34638941 | Int J Mol Sci | MERTK+/hi M2c Macrophages Induced by Baicalin Alleviate Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01737 | 34632357 | J Transl Autoimmun | Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis. | 2021 | Details |
| A01741 | 34630909 | World J Diabetes | Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis. | 2021 | Details |
| A01750 | 34629256 | Nutr Metab Cardiovasc Dis | Extent and features of liver steatosis in vitro pave the way to endothelial dysfunction without physical cell-to-cell contact. | 2021 | Details |
| A01754 | 34629052 | Lipids Health Dis | Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico. | 2021 | Details |
| A01755 | 34628896 | Ann Palliat Med | Accuracy of FibroTouch in assessing liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus. | 2021 | Details |
| A01761 | 34627692 | Nutr Metab Cardiovasc Dis | Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society. | 2021 | Details |
| A01767 | 34624564 | Clin Gastroenterol Hepatol | Serum Fibrosis Tests Guide Prognosis in Metabolic Dysfunction-Associated Fatty Liver Disease Patients Referred From Primary Care. | 2021 | Details |
| A01779 | 34620897 | Sci Rep | A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men. | 2021 | Details |
| A01796 | 34611618 | JHEP Rep | External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population. | 2021 | Details |
| A01804 | 34609237 | Health Informatics J | Trend research of vitamin D receptor: Bibliometric analysis. | 2021 | Details |
| A01806 | 34608587 | Hepatol Int | Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease. | 2021 | Details |
| A01818 | 34604973 | Eur Rev Med Pharmacol Sci | Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: a systematic review. | 2021 | Details |
| A01828 | 34602548 | Biol Pharm Bull | Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells. | 2021 | Details |
| A01831 | 34601620 | J Gastroenterol | Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan. | 2021 | Details |
| A01835 | 34600973 | J Hepatol | ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD. | 2021 | Details |
| A01846 | 34591986 | Hepatology | OTUB1 alleviates NASH through inhibition of the TRAF6-ASK1 signaling pathways. | 2021 | Details |
| A01853 | 34588764 | Drug Des Devel Ther | Non-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex Disease. | 2021 | Details |
| A01890 | 34572279 | Biomedicines | Associations of Dietary Lipid-Soluble Micronutrients with Hepatic Steatosis among Adults in the United States. | 2021 | Details |
| A01893 | 34571189 | J Nutr Biochem | Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice. | 2021 | Details |
| A01896 | 34568346 | Front Cell Dev Biol | Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis. | 2021 | Details |
| A01910 | 34564946 | Liver Int | A novel quantitative ultrasound technique for identifying non-alcoholic steatohepatitis. | 2021 | Details |
| A01912 | 34564899 | J Intern Med | Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies. | 2021 | Details |
| A01920 | 34561962 | J Diabetes Investig | Metabolic associated fatty liver disease is a risk factor for chronic kidney disease. | 2021 | Details |
| A01953 | 34555346 | Lancet Gastroenterol Hepatol | Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. | 2021 | Details |
| A01986 | 34540943 | Visc Med | Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD). | 2021 | Details |
| A01987 | 34540134 | Kans J Med | Bariatric Metabolic Surgery Reduced Liver Enzyme Levels in Patients with Non-Alcohol Fatty Liver Disease. | 2021 | Details |
| A01990 | 34537182 | Anal Biochem | Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease? | 2021 | Details |
| A02003 | 34533606 | Eur Radiol | Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD. | 2021 | Details |
| A02012 | 34531129 | Dig Liver Dis | Troglitazone inhibits hepatic oval cell proliferation by inducing cell cycle arrest through Hippo/YAP pathway regulation. | 2021 | Details |
| A02015 | 34530527 | Clin Mol Hepatol | Systematic review with meta-analysis: Non-alcoholic fatty liver disease and the association with pregnancy outcomes. | 2021 | Details |
| A02041 | 34522873 | EClinicalMedicine | Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART). | 2021 | Details |
| A02070 | 34511823 | J Clin Exp Hepatol | Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes! | 2020 | Details |
| A02071 | 34511822 | J Clin Exp Hepatol | Hepatogenous Diabetes: A Primer. | 2021 | Details |
| A02081 | 34511367 | Obes Res Clin Pract | Accuracy of ultrasound diagnosis of nonalcoholic fatty liver disease in patients with classes II and III obesity: A pathological image study. | 2021 | Details |
| A02090 | 34509375 | Surg Obes Relat Dis | Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years. | 2021 | Details |
| A02097 | 34508669 | Lancet Gastroenterol Hepatol | Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa. | 2021 | Details |
| A02103 | 34506332 | Clin Transl Gastroenterol | The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD. | 2021 | Details |
| A02107 | 34505423 | Endocrinol Diabetes Metab | Oxy210, a novel inhibitor of hedgehog and TGF-β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice. | 2021 | Details |
| A02112 | 34503151 | Cancers (Basel) | Host-Microbiota Interactions in Liver Inflammation and Cancer. | 2021 | Details |
| A02115 | 34501590 | Int J Environ Res Public Health | Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study. | 2021 | Details |
| A02126 | 34497431 | World J Gastroenterol | Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease. | 2021 | Details |
| A02137 | 34491886 | Gut Microbes | Associations of the gut microbiome with hepatic adiposity in the Multiethnic Cohort Adiposity Phenotype Study. | 2022 | Details |
| A02157 | 34482357 | Med Sci Monit | Live Combined B. subtilis and E. faecium Alleviate Liver Inflammation, Improve Intestinal Barrier Function, and Modulate Gut Microbiota in Mice with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02174 | 34474519 | Endocrinol Metab (Seoul) | Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability. | 2021 | Details |
| A02185 | 34469884 | Dig Dis | Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm. | 2021 | Details |
| A02186 | 34469716 | Cell Rep | Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota. | 2021 | Details |
| A02189 | 34467835 | Br J Nutr | Cardiometabolic traits mediated the relationship from early life famine exposure to adulthood nonalcoholic fatty liver disease risk. | 2021 | Details |
| A02200 | 34463867 | Semin Immunopathol | Functional heterogeneity of CD4+ T cells in liver inflammation. | 2021 | Details |
| A02203 | 34461916 | Environ Health | Associations of acrylamide with non-alcoholic fatty liver disease in American adults: a nationwide cross-sectional study. | 2021 | Details |